Citius Pharmaceuticals (CTXR)
(Delayed Data from NSDQ)
$0.66 USD
-0.07 (-9.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.66 0.00 (-0.72%) 4:32 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.06 | 0.00% |
Earnings Summary
For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.06 per share, missing the Zacks Consensus Estimate of $0.13 per share. This reflects a negative earnings surprise of 146.15%. Look out for CTXR's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year increase of 14.29%.
Earnings History
Price & Consensus
Zacks News for CTXR
Citius (CTXR) Posts Top-Line Data From Pivotal Lymphoma Study
CTXR: What are Zacks experts saying now?
Zacks Private Portfolio Services